Plexus Revenue Surges 28%, But EPS Misses and Stock Dips

Plexus (PLXS), ranking by market capitalization reported its fiscal 2026 Q3 earnings on Aug 07th, 2026. The company demonstrated robust top-line growth, significantly outperforming consensus estimates with revenue reaching $1.30 billion against a $1.23 billion forecast. While EPS came in below the $2.13 expectation at $1.61, management provided strong forward-looking guidance for the fourth quarter, projecting EPS between $2.47 and $2.63, signaling confidence in sustained operational momentum and margin expansion despite near-term macroeconomic headwinds.

Revenue

The total revenue of Plexus increased by 28.1% to $1.30 billion in 2026 Q3, up from $1.02 billion in 2025 Q3. This growth was driven by diverse contributions across its primary business units: Aerospace/Defense generated $232.84 million, Healthcare/Life Sciences contributed $482.44 million, and the Industrial segment accounted for $589.49 million, culminating in total net sales of $1.30 billion.

Earnings/Net Income

Plexus's EPS declined 3.6% to $1.61 in 2026 Q3 from $1.67 in 2025 Q3. Meanwhile, the company's net income declined to $42.99 million in 2026 Q3, down 4.7% from $45.12 million reported in 2025 Q3. This contraction in profitability reflects higher operational costs and investment expenditures that temporarily pressured bottom-line margins during the quarter.

Price Action

The stock price of Plexus has edged down 2.47% during the latest trading day, has jumped 10.95% during the most recent full trading week, and has climbed 4.90% month-to-date.

Post-Earnings Price Action Review

Following the earnings release, Plexus shares experienced mixed trading dynamics, reflecting a divergence between strong revenue performance and softer earnings metrics. The stock declined slightly by 2.47% on the latest trading day, indicating some profit-taking or caution among investors regarding the net income contraction. However, this short-term pullback was offset by a robust 10.95% gain over the most recent full trading week, suggesting broader market appreciation for the company's strategic positioning and positive fourth-quarter guidance. Additionally, the stock has climbed 4.90% month-to-date, demonstrating underlying investor confidence in Plexus's long-term growth trajectory despite near-term volatility. The price action highlights a market that is weighing immediate earnings misses against the potential for margin improvement and sustained revenue growth in subsequent quarters.

CEO Commentary

Plexus Corporation, led by Chief Executive Officer John L. McCallum, reported a resilient third quarter of 2026, characterized by strategic navigation through macroeconomic headwinds while maintaining operational discipline. The leadership team emphasized that despite challenges in certain end markets, the company successfully leveraged its high-mix, low-volume model to drive growth, particularly in life sciences and industrial automation sectors. McCallum highlighted significant investments in automation and digital supply chain capabilities as core strategic priorities aimed at enhancing efficiency and customer value. While acknowledging near-term volatility in global demand, the CEO maintained a cautiously optimistic tone, noting that the company’s diversified portfolio and strong balance sheet position it well for long-term value creation. The focus remains on executing against strategic initiatives to improve margins and capitalize on emerging opportunities in advanced manufacturing, ensuring sustainable profitability amidst an evolving competitive landscape.

Guidance

For the full fiscal year 2026, Plexus Corporation provided specific quantitative targets reflecting its current operational performance. The company reported a final Earnings Per Share (EPS) of $1.61, demonstrating solid bottom-line results. Total revenue for the quarter concluded at $1,304,778,000, underscoring the scale of its operations and market presence. Net income was recorded at $42,993,000, indicating healthy profitability margins despite the complex market environment. Management indicated that these figures align with their broader financial objectives, balancing growth investments with cost control measures. Qualitative expectations suggest a continued focus on maintaining this level of financial discipline in subsequent quarters, with an emphasis on optimizing working capital and sustaining the strategic investments in technology and infrastructure that drive their competitive advantage. The guidance underscores a commitment to delivering consistent shareholder value through operational excellence and strategic market positioning.

Additional News

Institutional activity surrounding Plexus Corp. (NASDAQ:PLXS) has intensified, with the California State Teachers Retirement System (CalSTRS) increasing its stake by 22.3% during the first quarter. CalSTRS purchased an additional 5,728 shares, bringing its total holding to 31,393 shares valued at approximately $6.36 million, representing 0.12% of the company. This move aligns with a broader trend among smaller institutional investors, including Covestor Ltd, which boosted its position by 207.7% to 240 shares, and Farther Finance Advisors LLC, which grew its stake by 114.7%. Other notable activity includes Allworth Financial LP lifting its position by 20.8% and EverSource Wealth Advisors LLC expanding its holding by 583.3% in the second quarter. These acquisitions occur against a backdrop where institutional investors collectively hold 94.45% of the company’s stock, signaling strong institutional conviction in Plexus’s long-term strategic direction and market position.